Loading…
Skeletal muscle mass and risk of advanced adenoma in surveillance colonoscopy
Background and Aim Sarcopenia has been suggested to be associated with chronic inflammation and insulin resistance. This study aimed to evaluate whether low muscle mass is associated with the incidence and recurrence of advanced colorectal adenoma. Methods We conducted a cohort study including 14 70...
Saved in:
Published in: | Journal of gastroenterology and hepatology 2020-12, Vol.35 (12), p.2088-2095 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background and Aim
Sarcopenia has been suggested to be associated with chronic inflammation and insulin resistance. This study aimed to evaluate whether low muscle mass is associated with the incidence and recurrence of advanced colorectal adenoma.
Methods
We conducted a cohort study including 14 701 participants who underwent first‐time screening colonoscopy between 2003 and 2012 and follow‐up colonoscopy until 2017. Skeletal muscle mass was measured using a bioelectrical impedance analyzer and divided by body weight to calculate the skeletal muscle mass index (SMI).
Results
During a median 47 (interquartile range, 35–58) months of follow‐up, overall and advanced adenoma developed in 2988 (20.3%) and 207 (1.41%) participants, respectively. In multivariate analysis using models adjusted for baseline adenoma risk, lifestyle factors, markers for insulin resistance and chronic inflammation, and metabolic syndrome, decreasing SMI quartiles were associated with increased risk of occurrence of advanced adenoma and overall adenoma. The adjusted hazard ratios (95% confidence intervals) comparing SMI quartiles 3, 2, and 1 to quartile 4 were 1.57 (1.03–2.41), 1.22 (0.78–1.92), and 1.77 (1.13–2.76), respectively, for advanced adenoma (P for trend = 0.049) and 1.05 (0.95–1.17), 1.09 (0.98–1.21), and 1.26 (1.13–1.41), respectively, for overall adenoma (P for trend |
---|---|
ISSN: | 0815-9319 1440-1746 |
DOI: | 10.1111/jgh.15082 |